BU-4704, a new member of the xanthocillin class.
Bristol-Myers Squibb Research Institute, Tokyo, Japan.
M
M
Tsunakawa
N
N
Ohkusa
S
S
Kobaru
Y
Y
Narita
S
S
Murata
Y
Y
Sawada
T
T
Oki
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000737:chemistry / Q000302:isolation & purification* / Q000494:pharmacology; D000935:Antifungal Agents / Q000737:chemistry / Q000302:isolation & purification* / Q000494:pharmacology; D002070:Butadienes / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology; D005285:Fermentation; D006801:Humans; D008546:Melanoma, Experimental / Q000188:drug therapy; D051379:Mice; D008826:Microbial Sensitivity Tests; D009570:Nitriles / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000903:Antibiotics, Antineoplastic; D000935:Antifungal Agents; C081423:BU 4704; D002070:Butadienes; D009570:Nitriles